With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
News|Articles|March 17, 2026
Challenging Cases®: Firsthand insight into oncology decision‑making
Author(s)IntrinsiQ Specialty Solutions
Through interactive, quantitative live and virtual double-blinded case-based sessions followed by a national key opinion leader data-focused discussion, Challenging Cases offers a window into how oncologists select treatment options, balance clinical considerations, and respond to complex patient scenarios, providing insight into the factors shaping real-world treatment decisions.
Related to this article
In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
CSafe's Aaron Mantia explains how lane, temperature range, duration and product cost shape thermal protection choices for bulk air cargo.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.
PAXAFE's Mark Talens explains why real-time visibility starts with process redesign and how it speeds cold chain disposition decisions.
FDA’s final guidance on prescription drug use-related software clarifies when companion app content is labeling, promotion or belongs in the PI.
At LogiPharma USA 2026, Cold Chain Technologies' Anthony "TJ" Rizzo discusses cold chain expertise gaps and how data tools are reshaping the profession.
AI is starting to resolve shipment exceptions and flag demand shifts, but early deployments show that connected data and context come first and that accountability stays with people.
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
2
LogiPharma 2026: CSafe on Right-Sizing Bulk Air Cargo Protection
3
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
4
How Pharma Automation Cuts Human Touches and Error Risk
5